Last --
Change Today 0.00 / 0.00%
Volume 0.0
4502 On Other Exchanges
Symbol
Exchange
4502 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Teruo Sakurada

AgeTotal Calculated CompensationThis person is connected to 18 board members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background*

Mr. Teruo Sakurada has been a Corporate Auditor at Takeda Pharmaceutical Co. Ltd., since 2009. Mr. Sakurada served as General Manager of Osaka Branch Pharmaceutical Marketing Division of Takeda Pharmaceutical Co. Ltd. since 2000. He joined Takeda Pharmaceutical Co. Ltd in 1970 and served as its General Manager of Tohoku Branch Pharmaceutical Marketing Division since 2000; and Corporate Officer since 2006.

Corporate Headquarters*

1-1, Doshomachi 4-chome
Osaka, -- 540-8645

Japan

Phone: 81 6 6204 2111
Fax: 81 6 6204 2880

Board Members Memberships*

2009-Present
Corporate Auditor

Education*

There is no Education data available.

Other Affiliations*

There is no Company Affiliations data available.

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4502:JP ¥4,928.00 JPY +34.50

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
Vincent A. Forlenza BDChairman, Chief Executive Officer and President
Becton, Dickinson and Company
$930.0K
Miles D. White Chairman, Chief Executive Officer and Chairman of Executive Committee
Abbott Laboratories
$1.9M
Robert L. Parkinson Jr.Chairman, Chief Executive Officer and President
Baxter International Inc.
$1.5M
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TAKEDA PHARMACEUTICAL CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.